v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (34,524) $ (14,682)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 2,301 1,807
Stock-based compensation 4,747 1,299
Accretion and amortization of premiums and discounts on investments, net (137) (222)
Loss on remeasurement of convertible notes 9,971  
Convertible note issuance costs included in net loss 361  
Unrealized foreign exchange loss (gain) 245 (527)
Non-cash operating lease costs 1,145 867
Amortization of debt issuance costs 137 86
Change in fair value of warrant liabilities 117 23
Provision for expected credit losses 135  
Changes in assets and liabilities:    
Accounts receivable (7,821) (2,849)
Inventory (6,990) (9,418)
Contract assets   413
Net investment in sales-type lease   173
Prepaid expenses and other current assets (2,860) 349
Other noncurrent assets (811) 120
Accounts payable 7,658 (1,235)
Operating lease liabilities (903) (955)
Accrued expenses and other liabilities (4,440) (199)
Net cash used in operating activities (31,669) (24,950)
Cash flows from investing activities    
Purchases of short-term investments (117,045) (4,940)
Maturities of short-term investments   42,000
Purchases of property and equipment (4,242) (1,307)
Capitalized software development costs (287) (790)
Net cash (used in) provided by investing activities (121,574) 34,963
Cash flows from financing activities:    
Proceeds from issuance of common stock in connection with IPO, net of underwriting costs 204,542  
Payment of third-party IPO costs (6,150)  
Proceeds from issuance of convertible notes 56,500  
Payment of third-party debt issuance costs (324)  
Proceeds from issuance of common stock upon exercise of stock options 3,034 407
Net cash provided by financing activities 257,602 407
Effect of exchange rate changes on cash and cash equivalents, and restricted cash (45) 469
Net increase in cash, cash equivalents and restricted cash 104,314 10,889
Cash, cash equivalents and restricted cash at beginning of period 34,909 31,677
Cash, cash equivalents and restricted cash at end of period 139,223 42,566
Supplemental disclosure of cash-flow information:    
Cash paid for interest 303 6
Noncash investing and financing items:    
Conversion of convertible preferred stock to common stock 234,996  
Conversion of convertible notes to common stock 66,471  
Reclassification of deferred offering costs to additional paid-in capital upon IPO 6,705  
Vesting of early exercised stock options 230 9
Right-of-use assets obtained in exchange for new operating lease liabilities 10,807 134
Conversion of preferred stock warrants to common stock warrants 364  
Equipment transferred to inventory 10 169
Property and equipment included in accounts payable and accrued liabilities $ 601 $ 196